Skip to the page

Data / Drug companies / Baxter Healthcare Corporation

Baxter Healthcare Corporation: 37 products in the FDA NDC directory, labeler code 36000

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Baxter Healthcare Corporation (labeler code 36000) lists 37 products in the FDA National Drug Code Directory, covering 21 finished drugs by generic name. By type: 37 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 3, 2026.

The request: Watch Baxter Healthcare Corporation (FDA labeler code 36000): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
36000
Products in commercial distribution
37
Packages
42
Finished drugs by generic name
21
Prescription products
37
Over the counter products
0
Flagged as original packager
35 of 35 products that carry the flag
Started marketing in the last 12 months
9
Earliest marketing start
September 25, 2012
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)37100%

Products by type

TypeProductsShare
Prescription drugs37100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Injection, solution1848.6%
Injection1540.5%
Injection, solution, concentrate25.4%
Injection, emulsion12.7%
Solution12.7%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Propofol36000-058Injection, emulsionGeneric drugs (ANDA)November 3, 2026
Metoclopramide36000-366Injection, solutionGeneric drugs (ANDA)September 11, 2026
Levetiracetam36000-265Injection, solution, concentrateGeneric drugs (ANDA)August 6, 2026
Ephedrine sulfate36000-336InjectionGeneric drugs (ANDA)July 8, 2026
Levocarnitine36000-368Injection, solutionGeneric drugs (ANDA)July 2, 2026
Dexmedetomidine Hydrochloride36000-262Injection, solution, concentrateGeneric drugs (ANDA)April 16, 2026
Phenylephrine hydrochloride36000-362InjectionGeneric drugs (ANDA)April 6, 2026
Phenylephrine hydrochloride36000-360InjectionGeneric drugs (ANDA)April 6, 2026
Phenylephrine hydrochloride36000-358InjectionGeneric drugs (ANDA)April 6, 2026
Acetaminophen36000-372Injection, solutionGeneric drugs (ANDA)May 21, 2025
Dihydroergotamine mesylate36000-300Injection, solutionGeneric drugs (ANDA)January 7, 2025
Levetiracetam36000-356InjectionGeneric drugs (ANDA)October 2, 2023
Levetiracetam36000-354InjectionGeneric drugs (ANDA)October 2, 2023
Levetiracetam36000-352InjectionGeneric drugs (ANDA)October 2, 2023
Regadenoson36000-364Injection, solutionGeneric drugs (ANDA)May 23, 2023
Sumatriptan36000-289InjectionGeneric drugs (ANDA)January 19, 2023
Naloxone hydrochloride36000-310Injection, solutionGeneric drugs (ANDA)November 7, 2022
Methocarbamol36000-302InjectionGeneric drugs (ANDA)July 14, 2022
Palonosetron Hydrochloride36000-326InjectionGeneric drugs (ANDA)November 12, 2021
Acetaminophen36000-306Injection, solutionGeneric drugs (ANDA)September 17, 2021
Naloxone hydrochloride36000-308Injection, solutionGeneric drugs (ANDA)January 29, 2021
Labetalol Hydrochloride36000-324Injection, solutionGeneric drugs (ANDA)January 26, 2021
Labetalol Hydrochloride36000-322Injection, solutionGeneric drugs (ANDA)January 26, 2021
Labetalol Hydrochloride36000-320Injection, solutionGeneric drugs (ANDA)January 26, 2021
Flumazenil36000-149InjectionGeneric drugs (ANDA)October 1, 2017

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.